Frederic Godderis, fractional Chief Strategy Officer at Rejuvenate Biomed, is a biopharmaceutical R&D leader and serial entrepreneur with extensive drug development, business development and corporate leadership experience. Throughout his career, he has contributed to the development of numerous drugs and established operating models, capabilities, and leadership structures in a variety of large and small biotech and pharma companies (J&J, Jazz Pharmaceuticals, Prothena Biosciences and Tranquis Therapeutics). In addition to his role at Rejuvenate Biomed he is co-founder and serves as board director and advisor at several early-stage biotech companies. Frederic received his MS from the K.U. Leuven University in Belgium.